Literature DB >> 15276961

Psychiatric disorders during pregnancy.

A D Cott1, K L Wisner.   

Abstract

Treating women with psychiatric disorders during pregnancy is a challenge for numerous reasons. Balancing the risks and benefits of symptoms and treatments is particularly important during pregnancy because both medication and maternal illness may have adverse effects on the fetus. Communication of options in the management of psychiatric disorders in pregnancy is vital to optimal treatment. One barrier to effective communication has been a paucity of research from which clinicians can draw information, particularly in the area of pharmacological treatment. However, emerging evidence points to the low risk of many psychotropic medications during pregnancy. Uncertainty must not prevent frank risk-benefit discussions from occurring between treating physicians and their pregnant patients. Psychiatrists can prepare themselves for management decisions by reviewing the current literature.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15276961     DOI: 10.1080/0954026031000136848

Source DB:  PubMed          Journal:  Int Rev Psychiatry        ISSN: 0954-0261


  6 in total

Review 1.  Interface of Women's Mental and Reproductive Health.

Authors:  Sermsak Lolak; Navid Rashid; Thomas N Wise
Journal:  Curr Psychiatry Rep       Date:  2005-06       Impact factor: 5.285

Review 2.  Preventing postpartum depression: review and recommendations.

Authors:  Elizabeth Werner; Maia Miller; Lauren M Osborne; Sierra Kuzava; Catherine Monk
Journal:  Arch Womens Ment Health       Date:  2014-11-25       Impact factor: 3.633

3.  Psychopharmacologic management of opioid-dependent women during pregnancy.

Authors:  Peter R Martin; Amelia M Arria; Gabriele Fischer; Karol Kaltenbach; Sarah H Heil; Susan M Stine; Mara G Coyle; Peter Selby; Hendrée E Jones
Journal:  Am J Addict       Date:  2009 Mar-Apr

4.  Nutritional factors associated with antenatal depressive symptoms in the early stage of pregnancy among urban South Indian women.

Authors:  Ammu Lukose; Asha Ramthal; Tinku Thomas; Ronald Bosch; Anura V Kurpad; Christopher Duggan; Krishnamachari Srinivasan
Journal:  Matern Child Health J       Date:  2014-01

5.  Rate of Chiari I malformation in children of mothers with depression with and without prenatal SSRI exposure.

Authors:  Rebecca C Knickmeyer; Samantha Meltzer-Brody; Sandra Woolson; Robert M Hamer; J Keith Smith; Kenneth Lury; John H Gilmore
Journal:  Neuropsychopharmacology       Date:  2014-05-20       Impact factor: 7.853

6.  The effect of ketamine on preventing postpartum depression.

Authors:  Mina Alipoor; Marzeyeh Loripoor; Majid Kazemi; Farshid Farahbakhsh; Ali Sarkoohi
Journal:  J Med Life       Date:  2021 Jan-Mar
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.